Caminha RDG,
Alcantara PL, Carvalho CG, Reia VCB, Capelozza ALA, Santos PSS. The impact of
medication-related osteonecrosis of the jaws on the quality of life in cancer
patients. J Clin Exp Dent. 2020;12(8):e725-9.
doi:10.4317/jced.56307
https://doi.org/10.4317/jced.56307
__________________________
References
|
1.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al.
American Association of Oral and Maxillofacial Surgeons position paper on
medication-related osteonecrosis of the jaw - 2014 update. J Oral Maxillofac
Surg. 2014;72:1938-56. |
|
|
|
|
|
2.
Capocci M, Romeo U, Guerra F, Mannocci A, Tenore G, Annibali S, et al.
Medication-related osteonecrosis of the jaws (MRONJ) and quality of life
evaluation: a pilot study. Clin Ter. 2017;168:e253-7. PMid:
28703840 |
|
|
|
|
|
3.
Barrios R, Bravo M, Gil-Montoya JA, Martínez-Lara I, García-Medina B, Tsakos
G. Oral and general health-related quality of life in patients treated for
oral cancer compared to control group. Health Qual Life Outcomes. 2015;13:1-8. |
|
|
|
|
|
4.
Slade GD. Derivation and validation of a short-form oral health impact
profile. Community Dent Oral Epidemiol. 1997;25:284-90. |
|
|
|
|
|
5.
Miksad RA, Lai K-C, Dodson TB, Woo S-B, Treister NS, Akinyemi O, et al.
Quality of life implications of bisphosphonate-associated osteonecrosis of
the jaw. Oncologist. 2011;16:121-32. |
|
|
|
|
|
6.
Stuani VT, Santos PSS, Damante CA, Zangrando MSR, Greghi SLA, Rezende MLR, et
al. Oral health impact profile of head and neck cancer patients after or
before oncologic treatment: an observational analytic case-control study.
Support Care Cancer. 2018;26:2185-9. |
|
|
|
|
|
7.
Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, et al.
Diagnosis and management of osteonecrosis of the jaw: a systematic review and
international consensus. J Bone Miner Res. 2015;30:3-23. |
|
|
|
|
|
8.
Nicolatou-Galitis O, Schiodt M, Mendes RA, Ripamonti C, Hope S, Drudge-Coates
L, et al. Medication-related osteonecrosis of the jaw: definition and best
practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral
Pathol Oral Radiol. 2019;127:117-35. |
|
|
|
|
|
9.
Kyrgidis A, Triaridis S, Kontos K, Patrikidou A, Andreadis C, Constantinidis
J, et al. Quality of life in breast cancer patients with
bisphosphonate-related osteonecrosis of the jaws and patients with head and
neck cancer: a comparative study using the EORTC QLQ-C30 and QLQ-HN35 questionnaires.
Anticancer Res. 2012;32:3527-34. PMid:
22843941 |
|
|
|
|
|
10.
Hendriks LE, Hermans BC, Van Den Beuken-van Everdingen MH, Hochstenbag MM,
Dingemans AM. Effect of bisphosphonates, denosumab, and radioisotopes on bone
pain and quality of life in patients with non-small cell lung cancer and bone
metastases: a systematic review. J Thorac Oncol. 2016;11:155-73. |
|
|
|
|
|
11.
Oteri G, De Ponte FS, Runci M, Peditto M, Marcianò A, Cicciù M.
Oral-health-related quality of life after surgical treatment of osteonecrosis
of the jaws. J Craniofac Surg. 2018;29:403-8. |
|
|
|
|
|
12.
Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity. Med
Care. 1996;34:220-33. |
|
|
|
|
|
13.
Barrios R, Tsakos G, García-Medina B, Martínez-Lara I, Bravo M. Oral
health-related quality of life and malnutrition in patients treated for oral
cancer. Support Care Cancer. 2014;22:2927-33. |
|
|
|
|
|
14.
Karbach J, Al-Nawas B, Moergel M, Daubländer M. Oral health-related quality
of life of patients with oral lichen planus, oral leukoplakia, or oral
squamous cell carcinoma. J Oral Maxillofac Surg. 2014;72:1517-22. |
|
|
|
|
|
15.
Shavi GR, Thakur B, Bhambal A, Jain S, Singh V, Shukla A. Oral health related
quality of life in patients of head and neck cancer attending cancer hospital
of Bhopal City, India. J Int oral Health. 2015;7:21-7. PMid:
26464534 PMCid: PMC4588784 |
|
|
|
|
|
16.
Santos PSS, Cremonesi AL, Quispe RA, Rubira CM. The impact of oral health on
quality of life in individuals with head and neck cancer after radiotherapy:
the importance of dentistry in psychosocial issues. Acta Odontol Latinoam.
2017;30:62-7. PMid:
29248940 |
|
|
|
|
|
17.
Kam D, Salib A, Gorgy G, Patel TD, Carniol ET, Eloy JA, et al. Incidence of
suicide in patients with head and neck cancer. JAMA Otolaryngol Head Neck
Surg. 2015;141:1075-81. |
|
|
|
|
|
18.
De Oliveira BH, Nadanovsky P. Psychometric properties of the Brazilian
version of the Oral Health Impact Profile-short form. Community Dent Oral
Epidemiol. 2005;33:307-14. |
|
|
|
|
|
19.
Sturrock A, Preshaw PM, Hayes C, Wilkes S. Perceptions and attitudes of
patients towards medication-related osteonecrosis of the jaw (MRONJ): a
qualitative study in England. BMJ Open. 2019;9:e024376. |
|
|
|
|
|
20.
Bagan JV, Cibrian RM, Lopez J, Leopoldo-Rodado M, Carbonell E, Bagán L, et
al.: Sclerosis in bisphosphonate-related osteonecrosis of the jaws and its
correlation with the clinical stages: study of 43 cases. Br J Oral Maxillofac
Surg, 2015;53:257-62. |
|
|
|
|
|
21.
Ribeiro GH, Chrun ES, Dutra KL, Daniel FI, Grando LJ. Osteonecrosis of the
jaws: a review and update in etiology and treatment. Braz J Otorhinolaryngol.
2017;pii: S1808-8694:30097-6. PMid:
28712852 |
|
|
|
|
|
22.
Farias D, Zen Filho EZ, de Oliveira TF, Tinôco-Araújo JE, Sampieri MB, et al.
Clinical and image findings in bisphosphonate-related osteonecrosis of the jaws.
J Craniofac Surg. 2013;24:1248-51. |
|
|
|
|
|
23.
Rathbone EJ, Brown JE, Marshall HC, Collinson M, Liversedge V, Murden GA, et
al. Osteonecrosis of the jaw and oral health-related quality of life after
adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence
trial subprotocol (BIG01/04). J Clin Oncol. 2013;31:2685-91. |
|